Press release from Companies: Cessatech reports successful outcome of pharmacokinetic trial in children of lead candidate

Press release from Companies: Cessatech reports first patient dosed in pivotal trial of lead product candidate

Press release from Companies: Second quarter report Q2-2022 – green light for the pivotal trial 0205

Press release from Companies: Good things are worth waiting for - welcome to the second half of 2022!

Press release from Companies: Cessatech reports Regulatory Green Light for trial 0205, the pivotal trial for CT001 - first patient expected shortly

Press release from Companies: Cessatech reports last patient dosed in pharmacokinetic trial in children of lead candidate

Press release from Companies: First quarter report Q1-2022 - preparing for the pivotal trial

Press release from Companies: Newsletter #6 - Mar 2022

Press release from Companies: Minutes from the Annual General Meeting in Cessatech A/S

Press release from Companies: Cessatech reports successful outcome of bioavailability trial 0204 with CT001

Press release from Companies: Cessatech A/S publishes annual report for the fiscal year 2021

Press release from Companies: Cessatech A/S ("Cessatech" or the "Company") hereby convenes the annual general meeting to be held on 17 March 2022.